Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noam Zelcer

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Molecular Biology of the Cell|January 3, 2019
FBXW7 regulates endothelial barrier function by suppression of the cholesterol synthesis pathway and prenylation of RhoBManon C A Pronk, Jisca Majolée, Anke Loregger, et al.
Molecular and Cellular Biology|January 23, 2014
The E3 ubiquitin ligase MARCH6 degrades squalene monooxygenase and affects 3-hydroxy-3-methyl-glutaryl coenzyme A reductase and the cholesterol synthesis pathwayNoam Zelcer, Laura J Sharpe, Anke Loregger, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2025
Structural basis for substrate selectivity by site-one protease revealed by studies with a small-molecule inhibitorAshley V Bullington, Ilaria Micallo, Bilkish Bajaj, et al.
The Journal of Biological Chemistry|July 31, 2020
Structural analysis of the LDL receptor-interacting FERM domain in the E3 ubiquitin ligase IDOL reveals an obscured substrate-binding siteLuca Martinelli, Athanassios Adamopoulos, Patrik Johansson, et al.
AIDS (London, England)|November 21, 2002
Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugsMaarten T Huisman, Johan W Smit, Kristel M L Crommentuyn, et al.
Cardiovascular Research|June 4, 2024
A suite of genome-engineered hepatic cells provides novel insights into the spatiotemporal metabolism of apolipoprotein B and apolipoprotein B-containing lipoprotein secretionAmber Meurs, Klevis Ndoj, Marlene van den Berg, et al.
Atherosclerosis|November 15, 2020
Regulation of intestinal LDLR by the LXR-IDOL axisNienke M van Loon, Suzanne A E van Wouw, Roelof Ottenhoff, et al.
Biochemical Pharmacology|December 12, 2003
Glucuronidation as a mechanism of intrinsic drug resistance in colon cancer cells: contribution of drug transport proteinsJeffrey Cummings, Noam Zelcer, John D Allen, et al.
The Journal of Biological Chemistry|March 2, 2012
Fibroblast growth factor-21 (FGF21) regulates low-density lipoprotein receptor (LDLR) levels in cells via the E3-ubiquitin ligase Mylip/Idol and the Canopy2 (Cnpy2)/Mylip-interacting saposin-like protein (Msap)Hai Thi Do, Timofey V Tselykh, Johanna Mäkelä, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2025
NPC1 trafficking via VPS41-dependent LAMP carriers regulates endosomal cholesterol homeostasisKlevis Ndoj, Matteo Tantucci, Paolo Sanza, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Molecular Biology of the Cell|January 3, 2019
FBXW7 regulates endothelial barrier function by suppression of the cholesterol synthesis pathway and prenylation of RhoBManon C A Pronk, Jisca Majolée, Anke Loregger, et al.
Molecular and Cellular Biology|January 23, 2014
The E3 ubiquitin ligase MARCH6 degrades squalene monooxygenase and affects 3-hydroxy-3-methyl-glutaryl coenzyme A reductase and the cholesterol synthesis pathwayNoam Zelcer, Laura J Sharpe, Anke Loregger, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2025
Structural basis for substrate selectivity by site-one protease revealed by studies with a small-molecule inhibitorAshley V Bullington, Ilaria Micallo, Bilkish Bajaj, et al.
The Journal of Biological Chemistry|July 31, 2020
Structural analysis of the LDL receptor-interacting FERM domain in the E3 ubiquitin ligase IDOL reveals an obscured substrate-binding siteLuca Martinelli, Athanassios Adamopoulos, Patrik Johansson, et al.
AIDS (London, England)|November 21, 2002
Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugsMaarten T Huisman, Johan W Smit, Kristel M L Crommentuyn, et al.
Cardiovascular Research|June 4, 2024
A suite of genome-engineered hepatic cells provides novel insights into the spatiotemporal metabolism of apolipoprotein B and apolipoprotein B-containing lipoprotein secretionAmber Meurs, Klevis Ndoj, Marlene van den Berg, et al.
Atherosclerosis|November 15, 2020
Regulation of intestinal LDLR by the LXR-IDOL axisNienke M van Loon, Suzanne A E van Wouw, Roelof Ottenhoff, et al.
Biochemical Pharmacology|December 12, 2003
Glucuronidation as a mechanism of intrinsic drug resistance in colon cancer cells: contribution of drug transport proteinsJeffrey Cummings, Noam Zelcer, John D Allen, et al.
The Journal of Biological Chemistry|March 2, 2012
Fibroblast growth factor-21 (FGF21) regulates low-density lipoprotein receptor (LDLR) levels in cells via the E3-ubiquitin ligase Mylip/Idol and the Canopy2 (Cnpy2)/Mylip-interacting saposin-like protein (Msap)Hai Thi Do, Timofey V Tselykh, Johanna Mäkelä, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2025
NPC1 trafficking via VPS41-dependent LAMP carriers regulates endosomal cholesterol homeostasisKlevis Ndoj, Matteo Tantucci, Paolo Sanza, et al.
Pageof 10